Trial Profile

A first-in-man trial of NPM-115 for chronic weight management in obese or overweight patients

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Exenatide (Primary)
Indications Obesity
Focus Adverse reactions; First in man

Most Recent Events

02 Apr 2024 New trial record
26 Mar 2024 Accoeding to Vivani Medical media release, the company plans to submit a new Investigational New Drug Application for NPM-115 in second half of 2024 and initiating a first-in-man trial after receiving regulatory clearance to proceed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com